BioLife Solutions Inc reports results for the quarter ended in December - Earnings Summary

BioLife Solutions

16/03/2023 21:01

* BioLife Solutions Inc  BLFS.OQ  reported a quarterly
adjusted
loss of $1.15​​ per share for the quarter ended in December. The
mean expectation of eight analysts for the quarter was for a
loss of 17 cents per share.
    * Revenue rose 18.6% to $44.26 million from a year ago;
analysts
expected $43.29 million. 
    * BioLife Solutions Inc's reported EPS for the quarter was a
loss
of $1.15​.
    * The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * BioLife Solutions Inc shares had risen by 18.0% this
quarter.
    * The company reported a quarterly loss of $49.11 million.
    * Wall Street's median 12-month price target for BioLife
Solutions
Inc is $31.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 16 at 09:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.17          -1.15          Missed
 Sep. 30 2022      -0.17          -0.23          Missed
 Jun. 30 2022      -0.21          -0.06          Beat
 Mar. 31 2022      -0.25          -0.17          Beat